|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Patento numeris | 3412672 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17747004.4 |
| Europos patento paraiškos padavimo data | 2017-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-11-10 |
| (86) | Numeris | PCT/CN2017/072891 |
| Data | 2017-02-04 |
| (87) | Numeris | WO 2017/133684 |
| Data | 2017-08-10 |
| (30) | Numeris | Data | Šalis |
| 201610082029 | 2016-02-05 | CN |
| (72) |
DING, Zhaozhong, CN
SUN, Fei, CN
HU, Yinghu, CN
ZHOU, Yilong, CN
WANG, Zheng, CN
ZHAO, Rui, CN
YANG, Ling, CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,
No. 369 Yuzhou South Road Haizhou District, Lianyungang, Jiangsu 222062,
CN
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 2-Butoksi-7-(4-(pirolidin-1-ilmetil) benzil)-5H-pirolo[3,2-d]pirimidin-4-amino, kaip TLR7 agonisto, kristalinė forma, jos gamybos būdas ir panaudojimas |
| CRYSTAL FORM A OF 2-BUTOXY-7-(4-(PYRROLIDIN-1-YLMETHYL) BENZYL)-5H-PYRROLO[3,2-D]PYRIMIDIN-4-AMINE AS TLR7 AGONIST, PREPARATION METHOD AND USE THEREOF |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-12-22 | 10 | 231.00 EUR |
| 2027-02-04 |